Body composition as a predictor of chemotherapy toxicity in patients with metastatic prostate cancer treated with docetaxel. (11th September 2015) - Cushen, S.J.; Power, D.G.; McDermot, R.; O'Sullivan, K.; Maceneaney, P.; Daly, L.; Ryan, A.M.